Cargando…

XPO1-Mediated EIF1AX Cytoplasmic Relocation Promotes Tumor Migration and Invasion in Endometrial Carcinoma

Dysregulation of eukaryotic translation initiation factor 1A, X-linked (EIF1AX), has been implicated in the pathogenesis of some cancers. However, the role of EIF1AX in endometrial carcinoma (EC) remains unknown. We investigated the EIF1AX expression in EC patients and assessed its tumorigenesis-ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yuhong, Lv, Chengyu, Sun, Jiandong, Lin, Zihang, Liu, Yue, Huang, Yuxiu, Chen, Yupeng, Li, Hua, Lian, Xiuli, Jiang, Xia, Zhang, Sheng, Wang, Shie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800903/ https://www.ncbi.nlm.nih.gov/pubmed/36589683 http://dx.doi.org/10.1155/2022/1361135

Ejemplares similares

Long noncoding RNA EIF1AX‐AS1 promotes endometrial cancer cell apoptosis by affecting EIF1AX mRNA stabilization
por: Lv, Chengyu, et al.
Publicado: (2022)

Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
por: Long, Huideng, et al.
Publicado: (2023)

Prognostic Indicators of EIF1AX-Mutated Thyroid Tumor Malignancy and Cancer Aggressiveness
por: Bandargal, Saruchi, et al.
Publicado: (2022)

Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells
por: Li, Yuhuan, et al.
Publicado: (2020)

The Sex Differences in Uveal Melanoma: Potential Roles of EIF1AX, Immune Response and Redox Regulation
por: Liu-Smith, Feng, et al.
Publicado: (2021)

Structure of the exportin Xpo4 in complex with RanGTP and the hypusine-containing translation factor eIF5A
por: Aksu, Metin, et al.
Publicado: (2016)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles
por: Elsherbini, Noha, et al.
Publicado: (2022)

Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis
por: Rose, Anna M., et al.
Publicado: (2018)

Chromosome territory relocation during DNA repair requires nuclear myosin 1 recruitment to chromatin mediated by ϒ-H2AX signaling
por: Kulashreshtha, Mugdha, et al.
Publicado: (2016)

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
por: Nakayama, Robert, et al.
Publicado: (2016)

SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity
por: De Meo, Simone, et al.
Publicado: (2020)

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas
por: Küsters-Vandevelde, Heidi V. N., et al.
Publicado: (2016)

DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma
por: Wu, Yalan, et al.
Publicado: (2022)

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia
por: Guillem, Flavia, et al.
Publicado: (2019)

EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion
por: Castagna, Maria Grazia, et al.
Publicado: (2020)

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
por: Sexton, Rachel, et al.
Publicado: (2019)

DNA double-strand breaks in heterochromatin elicit fast repair protein recruitment, histone H2AX phosphorylation and relocation to euchromatin
por: Jakob, Burkhard, et al.
Publicado: (2011)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

XPO1-dependent nuclear export as a target for cancer therapy
por: Azizian, Nancy G., et al.
Publicado: (2020)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

Dbf2–Mob1 drives relocalization of protein phosphatase Cdc14 to the cytoplasm during exit from mitosis
por: Mohl, Dane A., et al.
Publicado: (2009)

Inhibition of ER stress-mediated apoptosis in macrophages by nuclear-cytoplasmic relocalization of eEF1A by the HIV-1 Nef protein
por: Abbas, W, et al.
Publicado: (2012)

Inhibition of ER stress-mediated apoptosis in macrophages by nuclear-cytoplasmic relocalization of eEF1A by the HIV-1 Nef protein
por: Abbas, W, et al.
Publicado: (2012)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma
por: Sellin, Mark, et al.
Publicado: (2022)

Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors
por: Trkulja, Kyla L., et al.
Publicado: (2023)

Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis
por: Ou, Ling, et al.
Publicado: (2022)

Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
por: Azmi, Asfar S., et al.
Publicado: (2017)

The nuclear export factor Xpo1p targets Mad1p to kinetochores in yeast
por: Scott, Robert J., et al.
Publicado: (2009)

Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
por: Azmi, Asfar S., et al.
Publicado: (2015)

CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity
por: Saulino, David M., et al.
Publicado: (2018)

Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
por: Pianigiani, Giulia, et al.
Publicado: (2022)

Contrasting Patterns of Gene Duplication, Relocation, and Selection Among Human Taste Genes
por: Wang, Yupeng, et al.
Publicado: (2021)

XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose
por: Crochiere, Marsha L., et al.
Publicado: (2017)

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
por: Wu, Shan, et al.
Publicado: (2020)

Association of XPO1 Overexpression with NF-κB and Ki67 in Colorectal Cancer
por: Aladhraei, Mohammed, et al.
Publicado: (2019)

Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
por: Gargantilla, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2e4rf220blqa9q507j8f560omh